▶ 調査レポート

世界の肺がんの診断と治療市場:市場規模・現状・予測

• 英文タイトル:Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の肺がんの診断と治療市場:市場規模・現状・予測 / Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N7483資料のイメージです。• レポートコード:QYR9N7483
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別(非小細胞肺がん、小細胞肺がん)、用途別(病院、がん研究センター)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・肺がんの診断と治療の世界市場規模
・主要企業別市場シェア
・肺がんの診断と治療の世界市場規模:種類別(非小細胞肺がん、小細胞肺がん)
・肺がんの診断と治療の世界市場規模:用途別(病院、がん研究センター)
・肺がんの診断と治療のアメリカ市場規模(種類別、用途別)
・肺がんの診断と治療のヨーロッパ市場規模(種類別、用途別)
・肺がんの診断と治療の中国市場規模(種類別、用途別)
・肺がんの診断と治療の日本市場規模(種類別、用途別)
・肺がんの診断と治療の東南アジア市場規模(種類別、用途別)
・肺がんの診断と治療のインド市場規模(種類別、用途別)
・肺がんの診断と治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・肺がんの診断と治療の世界市場予測(2019年-2025年)
・肺がんの診断と治療の地域別市場予測(2019年-2025年)
...

Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the growth of the market.
In 2018, the global Lung Cancer Diagnosis and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lung Cancer Diagnosis and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Diagnosis and Therapeutics development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eli Lilly
Sanofi
ArQule
Daiichi Sankyo
Celgene
Merck
Pfizer
Boehringer Ingelheim
Roche
Genentech
GSK
Pharmacyclics
Novartis
Bayer
Bristol-Myers Squibb
Eisai
AbbVie

Market segment by Type, the product can be split into
Non-Small Cell Lung Cancer
Small Cell Lung Cancer

Market segment by Application, split into
Hospitals
Cancer Research Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lung Cancer Diagnosis and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer Diagnosis and Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lung Cancer Diagnosis and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Small Cell Lung Cancer
1.4.3 Small Cell Lung Cancer
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lung Cancer Diagnosis and Therapeutics Market Size
2.2 Lung Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Lung Cancer Diagnosis and Therapeutics Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Diagnosis and Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lung Cancer Diagnosis and Therapeutics Market Size by Manufacturers
3.1.1 Global Lung Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lung Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.3 Key Players Lung Cancer Diagnosis and Therapeutics Product/Solution/Service
3.4 Date of Enter into Lung Cancer Diagnosis and Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019)
4.2 Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
5.2 Lung Cancer Diagnosis and Therapeutics Key Players in United States
5.3 United States Lung Cancer Diagnosis and Therapeutics Market Size by Type
5.4 United States Lung Cancer Diagnosis and Therapeutics Market Size by Application

6 Europe
6.1 Europe Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
6.2 Lung Cancer Diagnosis and Therapeutics Key Players in Europe
6.3 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Type
6.4 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Application

7 China
7.1 China Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
7.2 Lung Cancer Diagnosis and Therapeutics Key Players in China
7.3 China Lung Cancer Diagnosis and Therapeutics Market Size by Type
7.4 China Lung Cancer Diagnosis and Therapeutics Market Size by Application

8 Japan
8.1 Japan Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
8.2 Lung Cancer Diagnosis and Therapeutics Key Players in Japan
8.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Type
8.4 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
9.2 Lung Cancer Diagnosis and Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Type
9.4 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Application

10 India
10.1 India Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
10.2 Lung Cancer Diagnosis and Therapeutics Key Players in India
10.3 India Lung Cancer Diagnosis and Therapeutics Market Size by Type
10.4 India Lung Cancer Diagnosis and Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size (2014-2019)
11.2 Lung Cancer Diagnosis and Therapeutics Key Players in Central & South America
11.3 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Type
11.4 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.2.4 Eli Lilly Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.3.4 Sanofi Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 ArQule
12.4.1 ArQule Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.4.4 ArQule Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.4.5 ArQule Recent Development
12.5 Daiichi Sankyo
12.5.1 Daiichi Sankyo Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.5.4 Daiichi Sankyo Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.5.5 Daiichi Sankyo Recent Development
12.6 Celgene
12.6.1 Celgene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.6.4 Celgene Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.6.5 Celgene Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.7.4 Merck Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.8.4 Pfizer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.9.4 Boehringer Ingelheim Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 Roche
12.10.1 Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lung Cancer Diagnosis and Therapeutics Introduction
12.10.4 Roche Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
12.10.5 Roche Recent Development
12.11 Genentech
12.12 GSK
12.13 Pharmacyclics
12.14 Novartis
12.15 Bayer
12.16 Bristol-Myers Squibb
12.17 Eisai
12.18 AbbVie

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lung Cancer Diagnosis and Therapeutics Key Market Segments
Table Key Players Lung Cancer Diagnosis and Therapeutics Covered
Table Global Lung Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size Market Share by Type 2014-2025
Figure Non-Small Cell Lung Cancer Figures
Table Key Players of Non-Small Cell Lung Cancer
Figure Small Cell Lung Cancer Figures
Table Key Players of Small Cell Lung Cancer
Table Global Lung Cancer Diagnosis and Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Research Centers Case Studies
Figure Lung Cancer Diagnosis and Therapeutics Report Years Considered
Table Global Lung Cancer Diagnosis and Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019
Figure Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions 2014-2019
Figure Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Lung Cancer Diagnosis and Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Share by Manufacturers in 2018
Table Global Lung Cancer Diagnosis and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Diagnosis and Therapeutics Product/Solution/Service
Table Date of Enter into Lung Cancer Diagnosis and Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Type (2014-2019)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Application (2014-2019)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Application in 2018
Figure United States Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table United States Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table United States Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Europe Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Europe Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Europe Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure China Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table China Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table China Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Japan Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Japan Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Japan Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure India Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table India Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table India Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Lung Cancer Diagnosis and Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2018-2019)
Table Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lung Cancer Diagnosis and Therapeutics Market Share by Type (2014-2019)
Table Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lung Cancer Diagnosis and Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table ArQule Company Details
Table ArQule Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure ArQule Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table ArQule Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Celgene Company Details
Table Celgene Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Celgene Recent Development
Table Merck Company Details
Table Merck Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Roche Company Details
Table Roche Revenue in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Genentech Company Details
Table GSK Company Details
Table Pharmacyclics Company Details
Table Novartis Company Details
Table Bayer Company Details
Table Bristol-Myers Squibb Company Details
Table Eisai Company Details
Table AbbVie Company Details
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Regions in 2025
Figure United States Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lung Cancer Diagnosis and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size by Product (2019-2025)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size by Product in 2025
Table Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2019-2025)
Figure Global Lung Cancer Diagnosis and Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources